Patients with Refractory Seizures

Devinsky, Orrin
May 1999
New England Journal of Medicine;05/20/99, Vol. 340 Issue 20, p1565
Academic Journal
Focuses on the patients with refractory epilepsy in the United States. Poor response to antiepileptic therapy; Classification of seizures; Diagnostic considerations; Therapeutic considerations; Alternative therapies; The effects of refractory epilepsy.


Related Articles

  • Intravenous Levetiracetam In Children With Seizures: A Prospective Safety Study. Yu-tze Ng; Hastriter, Eric V.; Cardenas, Javier F.; Khoury, Emily M.; Chapman, Kevin E. // Journal of Child Neurology;May2010, Vol. 25 Issue 5, p551 

    In 2006, intravenous levetiracetam received US Food and Drug Administration (FDA) approval for adjunctive treatment of partial onset seizures in adults with epilepsy, 16 years or older. We have established the safety, tolerability, and dosage of intravenous levetiracetam in children. This...

  • Epilepsy. Bain, Peter; Blass, John; Jenkins, Harri; Johnson, Michael // Current Medical Literature: Neurology;2011, Vol. 27 Issue 4, p126 

    The article comments on studies on epilepsy. One study showed that lamotrigine works better in treating partial epilepsy and makes the patient seizure-free for 6 months or longer. A study discussed that generic anti-epileptic drugs (AEDs) bring results similar to the branded ones with...

  • Transcallosal resection of hypothalamic hamartoma for gelastic epilepsy. J. R. Parr; R. Stacey; J. Rosenfeld; Y. Hart; P. Pretorius; S. Nijhawan; Z. Zaiwalla; M. McShane // Child's Nervous System;Feb2008, Vol. 24 Issue 2, p275 

    Abstract Introduction  Hypothalamic hamartomas (HHs) are commonly associated with severe epilepsy resistant to anticonvulsant therapy. Historically, surgical resection of HHs resulted in considerable morbidity. Discussion  Two series of patients who...

  • Histamine as an Anticonvulsant Inhibitory Neurotransmitter. Vohora, Divya; Pal, S. N.; Pillai, K. K. // Current Neuropharmacology;Oct2004, Vol. 2 Issue 4, p419 

    This review presents a link between histamine and epilepsy and provides the experimental evidence available so far on the effect of histamine and histaminergic agents in various seizure models. Agents that deplete brain histamine potentiate experimental convulsions while those enhancing tend to...

  • What is the easier and more reliable dose calculation for iv Phenytoin in children at risk of developing convulsive status epilepticus, 18 mg/kg or 20 mg/kg? Prasad, Manish; Shenton, Priya; Dietz, Sanne; Saroha, Vivek; Whitehouse, William P. // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Background: With the Convulsive Status Guidelines due for renewal, we wondered if a phenytoin dose of '20 mg/kg' would be easier to calculate correctly and therefore safer than the current '18 mg/kg'. An educational exercise in dose calculation was therefore undertaken to assess ease of...

  • Catamenial Epilepsy: A Case Report. Shrestha, Isha Dhungana // Nepal Journal of Neuroscience;2012, Vol. 9 Issue 2, p76 

    Seizure disorder associated with menstrual cycles of a female patient is termed as catamenial epilepsy. Though the terminology has been in use since the ancient time, no case has been reported in Nepal. Here we report a case of an 18 year old lady, who has been having seizures for last 5 years,...

  • Epilepsy. Smith, D.J.; Mucklow, J.C. // British Medical Journal;4/14/1979, Vol. 1 Issue 6169, p1000 

    Examines drugs used in treating epilepsy. Signs and symptoms of epilepsy; Evaluation of the effectiveness of anticonvulsants used in treating epilepsy; Factors causing an increase in seizure incidence.

  • The choice of initial monotherapy in newly diagnosed epilepsy requires careful consideration of multiple factors.  // Drugs & Therapy Perspectives;Dec2009, Vol. 25 Issue 12, p14 

    When choosing an antiepileptic drug with which to initiate monotherapy in patients who are newly diagnosed with epilepsy, therapy should be tailored based on specific disease-, patient- and treatment-related features.

  • Keppra.  // Formulary;May2007, Vol. 42 Issue 5, p283 

    The article focuses on levetiracetam Keppra, an antiepileptic agent recommended for adjunctive therapy to treat primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy. Such therapy was approved on March 19, 2007 to treat patients aged 6 years old and above....


Read the Article


Sign out of this library

Other Topics